Literature DB >> 10405858

The validity of drug users' self-reports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities.

M W Langendam1, H J van Haastrecht, E J van Ameijden.   

Abstract

BACKGROUND: Epidemiological studies among drug users are often based on retrospective self-reports. However, among others, memory failure, being under the influence of drugs, psychopathology, misunderstanding of questions and socially desirable answering may generate inaccurate reporting.
METHODS: This study validated self-reported current (methadone dosage) and medium-term (main location of methadone dispensing and frequency of methadone programme attendance over the previous 4-6 months) aspects of methadone treatment in the Amsterdam AIDS cohort study among drug users, using data of the Central Methadone Register. In addition to descriptive measures, logistic regression analysis was used (adjusted for intra-individual correlation) to identify subgroups with incorrect reporting. Data collected at 4406 visits of 505 cohort participants were analysed.
RESULTS: Current methadone dosage was accurately reported (unweighted kappa [kappa]: 0.94, weighted kappa [kappa W]: 0.97). A low methadone dosage, short duration of school education and depressive or euphoric mood during the interview were significant and independent predictors of incorrect reporting of methadone dosage. For main location of dispensing kappa was 0.82, for frequency of programme attendance kappa was 0.53 and kappa W 0.87. There was a tendency to reporting the extreme answering categories. Infrequent programme attendance was the only significant predictor of incorrectly reporting frequency of programme attendance.
CONCLUSIONS: Drug users are able to give valid self-reports in a setting where social desirability does not play an important role. The main reasons of incorrect reporting were impaired cognitive functioning, memory failure and misunderstanding of questions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10405858     DOI: 10.1093/ije/28.3.514

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  25 in total

1.  Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions.

Authors:  E J van Ameijden; R A Coutinho
Journal:  J Epidemiol Community Health       Date:  2001-05       Impact factor: 3.710

2.  An assessment of factorial structure and health-related quality of life in problem drug users using the Short Form 36 Health Survey.

Authors:  Angela Buchholz; Anneke Krol; Fred Rist; Pythia T Nieuwkerk; Gerard M Schippers
Journal:  Qual Life Res       Date:  2008-07-12       Impact factor: 4.147

3.  Density of low-barrier opioid agonist clinics and risk of non-fatal overdose during a community-wide overdose crisis: A spatial analysis.

Authors:  Ofer Amram; Eugenia Socías; Ekaterina Nosova; Thomas Kerr; Evan Wood; Kora DeBeck; Kanna Hayashi; Nadia Fairbairn; Julio Montaner; M J Milloy
Journal:  Spat Spatiotemporal Epidemiol       Date:  2019-07-04

4.  Alterations to pre-pulse inhibition (PPI) in chronic cannabis users are secondary to sustained attention deficits.

Authors:  Kirsty Elizabeth Scholes; Mathew Thomas Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2009-10-09       Impact factor: 4.530

5.  High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.

Authors:  Maria Eugenia Socías; Evan Wood; Stephanie Lake; Seonaid Nolan; Nadia Fairbairn; Kanna Hayashi; Hennady P Shulha; Seagle Liu; Thomas Kerr; M-J Milloy
Journal:  Addiction       Date:  2018-09-20       Impact factor: 6.526

6.  Prevalence and correlates of former injection drug use among young noninjecting heroin users in Chicago.

Authors:  Dita Broz; Lawrence J Ouellet
Journal:  Subst Use Misuse       Date:  2010-10       Impact factor: 2.164

7.  Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.

Authors:  M Eugenia Socías; Evan Wood; Will Small; Huiru Dong; Jean Shoveller; Thomas Kerr; Julio Montaner; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2016-09-20       Impact factor: 4.492

8.  Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs.

Authors:  Andreea A Artenie; Nanor Minoyan; Brendan Jacka; Stine Høj; Didier Jutras-Aswad; Élise Roy; Lise Gauvin; Geng Zang; Julie Bruneau
Journal:  CMAJ       Date:  2019-04-29       Impact factor: 8.262

9.  Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.

Authors:  Leslie Lappalainen; Seonaid Nolan; Sabina Dobrer; Cathy Puscas; Julio Montaner; Keith Ahamad; Huiru Dong; Thomas Kerr; Evan Wood; M-J Milloy
Journal:  Addiction       Date:  2015-08       Impact factor: 6.526

10.  Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies.

Authors:  C H S B van den Berg; T J W van de Laar; A Kok; F R Zuure; R A Coutinho; M Prins
Journal:  J Viral Hepat       Date:  2009-02-23       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.